The Ensign Group, Inc. ENSG is well-poised to grow due to the rising demand for healthcare services. Its moves to expand its ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

BioMarin Pharmaceutical, a global biotechnology company, sports a Zacks Rank #1 and a VGM Score of A. BMRN has a trailing ...

Hence, the recommended approach is to invest in low-beta stocks with a high-dividend yield and a favorable Zacks Rank. The University of Michigan’s Consumer Sentiment index, released last Friday ...

ENSG also has a Value Score of B. Due to its solid prospects, Ensign currently has a Zacks Rank #2 (Buy). Rising service and rental revenues are likely to support its top-line growth.

Ensign Group carries a Zacks Rank #2 (Buy) at present. The stock has gained 11.5% in the past six months compared with the industry’s 2.9% growth. The Medical sector and the S&P 500 ...